Potentials of organic tellurium-containing compound AS101 to overcome carbapenemase-producing Escherichia coli
CONCLUSION: The in vitro activities, mechanisms, and in vivo study of AS101 against CPEC were unveiled. Our finding provided further evidence for the antibiotic development of AS101.PMID:37516546 | DOI:10.1016/j.jmii.2023.07.002
Source: Journal of Microbiology, Immunology, and Infection - Category: Microbiology Authors: Tsung-Ying Yang Wei-Chun Hung Tsung-Han Tsai Po-Liang Lu Sheng-Fan Wang Liang-Chun Wang Yu-Tzu Lin Sung-Pin Tseng Source Type: research
More News: Allergy & Immunology | Clinical Trials | Epidemiology | Gastroenteritis | Genetics | Microbiology | Organic | PET Scan | Study